Investor Relations

Announcements and Others

Date Year  
2018.10.10 Appointment of Chief Operating Officer
2018.10.03 Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2018
2018.09.06 Company Information Sheet
2018.09.05 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2018
2018.08.31 List of Directors and their Role and Function
2018.08.31 (1) Appointment of Chief Medicine Officer (2) Appointment of Executive Director and Chief Executive Officer (3) Appointment of Chairman of Group Technical Committee, Director of University of Oxford TIssue Engineering Centre and Chairman of Stem Cell Division (4) Appointment of Vice President and (5) Appointment of Chief Technology Officer
2018.08.15 Approval by the Shenzhen Development and Reform Commission for the Establishment of A Shenzhen TIssue Engineering Laboratory by A Subsidiary of China Regenerative Medicine International Limited
2018.08.10 Interim Results Announcement for the Six Months Ended 30 June 2018
2018.08.01 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2018
2018.07.31 Notice of Board Meeting
2018.07.18 Company Information Sheet
2018.07.06 List of Directors and their Role and Function
2018.07.06 (1) Resignation of An Executive Director and Chief Executive Officer (2) Change of Composition of Nomination Committee (3) Change of An Authorised Representative (4) Change of Compliance Officer and (5) Change of Process Agent
2018.07.05 The World's First Bio-engineered Cornea "acornea" Formally Incorporating Into Civic the Medical-care System in Mainland China
2018.07.04 Change of Principal Place of Business in Hong Kong
2018.07.04 Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2018
2018.06.01 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2018
2018.06.01 Company Information Sheet
2018.05.31 List of Directors and their Role and Function
2018.05.31 (1) Resignation of Directors and (2) Change of Composition of Board Committees
2018.05.11 First Quarterly Results Announcement for the Three Months Ended 31 March 2018
2018.05.11 Poll Results of the Annual General Meeting Held on 11 May 2018
2018.05.02 Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2018
2018.04.30 Notice of Board Meeting
2018.04.17 Clarification Announcement
2018.04.16 Clarification Announcement
2018.04.06 Approval of the Re-registration of "activskin" the TIssue Engineered Skin Product
2018.04.03 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2018
2018.03.28 Notice of Annual General Meeting
2018.03.28 Proxy Form for the Annual General Meeting
2018.03.28 Annual Results Announcement for the Year Ended 31 December 2017
2018.03.28 Annual Results Announcement for the Year Ended 31 December 2017
2018.03.15 Notice of Board Meeting
2018.03.01 Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2018
2018.02.02 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2018
2018.01.25 Announcements and Notices - Acquisition of Shares by Listed Company in the PRC from A Substantial Shareholder of the Company
2018.01.24 Announcements and Notices - Increase in Shareholding by Substantial Shareholder
2018.01.16 Announcements and Notices - Voluntary Announcement
2018.01.02 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2017

IR Contact

China Regenerative Medicine International Limited

A:

Rooms 3006–10, 30/F., China Resources Building, 26 Harbour Road, Wanchai, Hong Kong

E: info@crmi.hk|

T: +852 3966 8388 |

F: +852 2802 0026